Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mirae Asset Healthcare Fund Direct Growth
Equity
Sectoral
Very High Risk
+27.23%
3Y annualised
-0.79% 1D
NAV: 27 Feb '26
₹44.13
Min. for SIP
₹99
Fund size
₹2,639.92 Cr
Expense ratio
0.47%
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 6 months | ₹30,000 | ₹30,331 | +1.10% | |
| 1 year | ₹60,000 | ₹62,084 | +3.47% | |
| 3 years | ₹1,80,000 | ₹2,39,787 | +33.22% | |
| 5 years | ₹3,00,000 | ₹4,68,570 | +56.19% |
Holdings (33)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 12.11% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 8.52% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 7.00% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 6.21% |
| Lupin Ltd. | Healthcare | Equity | 5.54% |
| Cipla Ltd. | Healthcare | Equity | 5.11% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.37% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 4.33% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 4.27% |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 3.62% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 3.51% |
| Laurus Labs Ltd. | Healthcare | Equity | 3.38% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 3.37% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | Equity | 3.31% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 3.24% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 3.03% |
| Eris Lifesciences Ltd. | Healthcare | Equity | 2.95% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.71% |
| Onesource Specialty Pharma Ltd. | Healthcare | Equity | 2.32% |
| Gland Pharma Ltd. | Healthcare | Equity | 2.04% |
| Mankind Pharma Ltd. | Healthcare | Equity | 1.84% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 1.19% |
| Biocon Ltd. | Healthcare | Equity | 1.04% |
| Dr. Lal Pathlabs Ltd. | Healthcare | Equity | 1.02% |
| Rubicon Research Ltd. | Healthcare | Equity | 0.97% |
| Sudeep Pharma Ltd. | Healthcare | Equity | 0.63% |
| Sagility Ltd. | Services | Equity | 0.60% |
| Deepak Nitrite Ltd. | Chemicals | Equity | 0.57% |
| Neogen Chemicals Ltd. | Chemicals | Equity | 0.47% |
| CORONA Remedies Ltd. | Healthcare | Equity | 0.35% |
| Wockhardt Ltd. | Healthcare | Equity | 0.11% |
| Mirae Asset Liquid Fund Direct- Growth | NA | Mutual Fund | 0.01% |
| Syngene International Ltd. | Healthcare | Equity | 0.00% |
See All
Minimum investments
Min. for 1st investment
₹5,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹99
Returns and rankings
Annualised returns
Absolute returns
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +18.9% | +27.2% | +18.4% | +21.4% |
| Category average (Equity Sectoral) | -2.1% | +22.1% | +14.6% | -- |
| Rank (Equity Sectoral) | 3 | 3 | 2 | -- |
Exit load, stamp duty and tax
Exit load
Exit load of 1% if redeemed within 1 year.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
VKVrijesh KaseraJun 2018 - PresentView details
VK
Vrijesh Kasera
Jun 2018 - Present
View details
TMTanmay MehtaApr 2025 - PresentView details
TM
Tanmay Mehta
Apr 2025 - Present
View details
About Mirae Asset Healthcare Fund Direct Growth
Mirae Asset Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Mirae Asset Mutual Fund. This scheme was made available to investors on 30 Nov 2007. Vrijesh Kasera is the Current Fund Manager of Mirae Asset Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹2,21,014 Cr and the Latest NAV as of 27 Feb 2026 is ₹44.13.
The Mirae Asset Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹99. Minimum Lumpsum Investment is ₹5,000. Exit load of 1% if redeemed within 1 year.
;
Investment Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)#13 in India
Total AUM₹2,21,013.51 Cr
Date of Incorporation30 Nov 2007
Launch Date30 Nov 2007
AddressUnit No.606 - 6th Floor,Windsor Building - Off. CST Road,Kalina, Santacruz (East), Mumbai 400098
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,